Spot Gold below 91-month peak but still supported - souzaovents

Having touched a 91-month towering happening Monday, Gilt prices on Tuesday remained subordinate any pressure, stemming from improved investor risk appetite following news of promising COVID-19 empirical vaccinum results in Moderna Inc's (Messenger RNA) early-stage trial.

Nonetheless, the downside May be limited because of renewed trade frictions between Beijing and Washington and a wave of stimulus measures by central Sir Joseph Banks across the ball, aimed to mitigate the wallop from the coronavirus pandemic on macroeconomic environment.

"Gold investors still see the opportunity on both sides of the mint right now because optimism from lockdowns is also inflationary," Stephen Innes, boss grocery store strategian at AxiCorp, said. "But the trade war itself is a huge risk as we saw through 2022, that was the primary driver for gold prices to move up," he added.

At 8:34 GMT today Spot Metallic was gaining 0.12% to $1,734.88 per Troy ounce, after touching an intraday low of $1,726.62, or a price level not seen since May 14th ($1,711.27). Meanwhile, Atomic number 79 futures for deliverance in June were gaining 0.08% on the twenty-four hours to trade at $1,735.80 per ounce, while Atomic number 47 futures for delivery in July were down 0.15% to trade at $17.442 per troy ounce.

The US Dollar Index number, which reflects the congener strength of the greenback against a basketful of six other major currencies, was retreating 0.06% on Tuesday to 99.56, later on earlier touching 99.38, or A level not seen since Crataegus oxycantha 11th (99.12).

Now investors will be looking for more clues on scheme outlook during Federal Reserve Chair Jerome Powell's testimony on Coronavirus Economic aid, Relief, and Economic Surety Act in front the Senate Banking, Lodging, and Urban Personal matters Committee at 14:00 GMT.

Additionally, at 18:00 Universal time Capital of Massachusetts Fed President Eric Rosengren will enter in a webinar focused on the shock of the COVID-19 public wellness crisis on the New England economy and Federal Reserve System actions taken in response.

Meanwhile, near-term rate of interest expectations were little altered. According to CME's FedWatch Tool, as of May 19th, investors saw a 95.0% chance of the Federal Reserve keeping borrowing costs at the current 0%-0.25% level at its policy meeting in June, compared with a 95.7% chance a solar day ago.

Daily Pivot Levels (traditional method of computing)

Central Pivot – $1,741.85
R1 – $1,756.29
R2 – $1,779.70
R3 – $1,794.13
R4 – $1,808.57

S1 – $1,718.44
S2 – $1,704.00
S3 – $1,680.60
S4 – $1,657.19

The RSI and the MACD on the 1H chart highlight a potentially limited downside for Gold. Contiguous patronage English hawthorn be ground in the area around today's low of $1,726.62, spell the 20-period EMA ($1,737.87) may restrict upside movement at first-class honours degree. Next, resistance may comprise expected at R1 pivot level ($1,756.29) and so, at the high from May 18th ($1,765.26).

Source: Miroslav Marinoff, a news editor at TradingPedia, is occupied with observing and reporting on the tendencies in the External Exchange Market and the US Stock Grocery.

Source: https://www.tradingpedia.com/2020/05/19/commodity-trading-gold-trades-below-recent-91-month-highs-as-promising-early-covid-19-vaccine-results-spur-investor-optimism/

Posted by: souzaovents.blogspot.com

Share this post